ABIOMED CEO Michael Minogue's 2022 pay slips 15% to $13M
ABIOMED reports 2022 executive compensation
By ExecPay News
Published: June 28, 2022
ABIOMED reported fiscal year 2022 executive compensation information on June 28, 2022.
In 2022, five ABIOMED executives received on average a compensation package of $4.7M, a 27% decrease compared to previous year.
Average pay of disclosed executives at ABIOMED
Michael R. Minogue, Chief Executive Officer, received $13M in total, which decreased by 15% compared to 2021. 52% of Minogue's compensation, or $6.6M, was in stock awards. Minogue also received $2.2M in non-equity incentive plan, $3.1M in option awards, $789K in salary, as well as $9.2K in other compensation.
For fiscal year 2022, the median employee pay was $131,893 at ABIOMED. Therefore, the ratio of Michael R. Minogue's pay to the median employee pay was 96 to one.
Todd A. Trapp, Chief Financial Officer, received a compensation package of $3M, which decreased by 36% compared to previous year. 57% of the compensation package, or $1.7M, was in stock awards.
Andrew J. Greenfield, Executive Vice President and Chief Commercial Officer, earned $2.8M in 2022, a 30% decrease compared to previous year.
Marc A. Began, General Counsel, received $2.6M in 2022, which decreases by 40% compared to 2021.
David M. Weber, Chief Operating Officer, earned $2.3M in 2022, a 46% decrease compared to previous year.
ABIOMED's fiscal year ends on March 31.
Related executives
You may also like
Source: SEC filing on June 28, 2022.